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Background
We sought to externally validate the ability of two exist-
ing risk stratification tools based primarily on biochem-
ical analyses to predict in-hospital mortality. The
systems were not restricted to specific presenting com-
plaints or selected diagnoses.
Methods
The study was completed as a prospective observational
cohort study at a regional teaching hospital.
The discriminatory power (ability to discriminate
between survivors and non-survivors) of the models was
estimated using the area under the receiver-operating
characteristics curve (AUROC). Values above 0.8 repre-
sent good discriminatory power. Calibration (accuracy
of the prediction) was assessed using Hosmer-Lemeshow
c
2 goodness of fit test with a p-value above 0.05 indicat-
ing acceptable calibration.
The blood tests used for calculation were drawn upon
admission, and always within 2 hours of arrival at the
department. As this was an observational study, only
analyses ordered by the treating physician were
included.
Results
3,050 consecutively admitted medical patients were
included. Eighty-four patients died while admitted (2.8 %).
When using the risk stratification system introduced
by Prytherch et al. we were able to include 2,671
patients (87.6 %). We found a good discriminatory
power with an AUROC of 0.852. Calculating the good-
ness of fit using the observed mortality data from the
original article, we found a Hosmer-Lemeshow c2 (eight
degrees of freedom) of 570.5, p < 0.001.
Using the system introduced by Froom and Shimoni,
we were only able to include 607 patients (19.9 %).
However, we found an AUROC of 0.864 indicating a
good discriminatory power. We were not able to calcu-
late the goodness of fit using mortality data from the
original article, as these were not provided. Thus using
the predicted values in our cohort, we found a Hosmer-
Lemeshow c2 (eight degrees of freedom) of 71.7, p <
0.001.
Conclusion
The two biochemical based risk stratification systems
tested in this external prospective study were both able
to predict in-hospital mortality with good discriminatory
power but unacceptable calibration. However, we were
only able to include 19.9 % of our cohort when calculat-
ing the score developed by Froom and Shimoni.
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